Christoph Heuser-Loy

10PUBLICATIONS
61CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsElectrical machines and drivesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 26, 2026
Enhancing Proteasome Activity in T Cells Alleviates Exhaustion and Improves Antitumor Immunity.

Ander de Blas, Massimo Andreatta, Asier Antoñana-Vildosola

|Dec 20, 2025
High-salt diet induces immune-independent re-differentiation, metabolic shut down and cell cycle arrest of melanoma.

Clivia Lisowski, Natascha E Stumpf, Katarzyna Jobin

|Oct 09, 2025
Targeting organelle function in T cells for cancer immunotherapy.

Jeremy G Baldwin, Christoph Heuser-Loy, Luca Gattinoni

|Aug 27, 2024
LSD1 inhibition improves efficacy of adoptive T cell therapy by enhancing CD8<sup>+</sup> T cell responsiveness.

Isabella Pallavicini, Teresa Maria Frasconi, Carlotta Catozzi

|Aug 08, 2024
LIM-domain-only 4 (LMO4) enhances CD8<sup>+</sup> T-cell stemness and tumor rejection by boosting IL-21-STAT3 signaling.

Roland C Schelker, Jessica Fioravanti, Fabio Mastrogiovanni

|Jun 12, 2024
Interleukin-10 gives exhausted chimeric antigen receptor (CAR) T cells a second breath.

Christoph Heuser-Loy

Pageof 2